SHANNON PHILLIPS: Open Payments
NPI 1811969165 · CARTHAGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 58 payments from 13 companies in 2025. Trend: 2023 $332 · 2024 $1,007 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 27 | $346 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Vanda Pharmaceuticals Inc. | 8 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Corium, LLC | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, FANAPT, FARXIGA, JARDIANCE, AIRSUPRA, CAPLYTA, BREZTRI, Azstarys.
Industry payments across TX — which companies pay providers there.
